Top Markets
Coin of the day
DiaSorin S.p.A. DiaSorin S.p.A.

DiaSorin S.p.A.

DIA
Rang in Aktien #3923
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Aktienkurs
$89.96
Marktkapitalisierung
$4.45B
Veränderung (1 Tag)
-0.16%
Veränderung (1 Jahr)
-14.59%
Land
IT
Handel DiaSorin S.p.A. (DIA)

Kategorie

Aktien-Split-Historie für DiaSorin S.p.A. (DIA)
Die Aktie DiaSorin S.p.A. (Symbol: DIA) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 26, 2026 statt.
Eine DIA-Aktie, die vor dem Aug 26, 2026 gekauft wurde, entspricht heute 0 DIA-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
1 x1
US